Citigroup Inc APELLIS PHARMACEUTICALS INC Transaction History

Citigroup Inc

  • $169 Billion
  • Q3 2024
Number of Shares
6,000
Previous 6,000 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
SELL
N/A
-498,000 Reduced 98.81%
6,000 $0
Q3 2023

Nov 09, 2023
BUY
N/A
504,000 New
504,000 $0
Q1 2023

May 11, 2023
BUY
N/A
106,000 Added 3533.33%
109,000 $0
Q4 2022

Feb 09, 2023
SELL
N/A
-147,000 Reduced 98.0%
3,000 $0
Q3 2022

Nov 10, 2022
SELL
N/A
-243,000 Reduced 61.83%
150,000 $292,000
Q2 2022

Aug 10, 2022
BUY
N/A
356,000 Added 962.16%
393,000 $587,000
Q1 2022

May 12, 2022
BUY
N/A
37,000 New
37,000 $59,000
Q4 2021

Feb 10, 2022
SELL
N/A
-2,126,000 Closed
0 $0
Q3 2021

Nov 10, 2021
BUY
N/A
2,126,000 New
2,126,000 $2.61 Million
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email